Shanghai Henlius Biotech, Inc. (HKG:2696)

Shanghai Henlius Biotech Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 6, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	40,871	31,006	12,881	7,555	6,957	11,984
Market Cap Growth	189.23%	140.72%	70.50%	8.59%	-41.95%	-53.03%
Enterprise Value	43,935	33,962	16,522	11,112	10,233	13,635
Last Close Price	75.20	57.05	23.70	13.90	12.80	22.05
PE Ratio	44.75	33.69	14.75	12.56	-	-
Forward PE	28.54	27.52	15.91	12.55	-	-
PS Ratio	5.51	4.18	2.11	1.27	1.91	5.80
PB Ratio	9.27	7.04	4.02	3.13	3.76	4.25
P/TBV Ratio	84.67	64.23	-	-	-	25.87
P/FCF Ratio	36.94	28.02	11.23	11.94	15.51	-
P/OCF Ratio	28.13	21.34	9.75	6.54	6.27	108.01
EV/Sales Ratio	5.92	4.58	2.71	1.87	2.82	6.60
EV/EBITDA Ratio	31.89	26.24	13.36	10.82	-	-
EV/EBIT Ratio	48.32	37.35	17.92	15.45	-	-
EV/FCF Ratio	39.71	30.70	14.40	17.57	22.82	-
Debt / Equity Ratio	0.91	0.91	1.21	1.87	2.25	1.14
Debt / EBITDA Ratio	2.91	2.91	2.96	4.07	-	-
Debt / FCF Ratio	3.62	3.62	3.39	7.13	9.27	-
Net Debt / Equity Ratio	0.70	0.70	0.94	1.41	1.81	0.82
Net Debt / EBITDA Ratio	2.37	2.37	2.44	3.31	-7.06	-3.63
Net Debt / FCF Ratio	2.77	2.77	2.63	5.37	7.48	-5.08
Asset Turnover	0.58	0.58	0.56	0.57	0.40	0.25
Inventory Turnover	2.51	2.51	2.07	1.95	1.44	1.44
Quick Ratio	0.54	0.54	0.34	0.34	0.27	0.35
Current Ratio	0.71	0.71	0.50	0.53	0.44	0.56
Return on Equity (ROE)	23.72%	23.72%	31.52%	28.52%	-35.35%	-35.81%
Return on Assets (ROA)	4.45%	4.45%	5.28%	4.33%	-4.88%	-6.11%
Return on Invested Capital (ROIC)	12.17%	13.01%	15.11%	12.67%	-14.32%	-16.48%
Return on Capital Employed (ROCE)	11.00%	11.00%	15.60%	13.50%	-16.00%	-15.80%
Earnings Yield	2.25%	2.97%	6.78%	7.96%	-11.30%	-10.08%
FCF Yield	2.71%	3.57%	8.91%	8.37%	6.45%	-3.79%
Buyback Yield / Dilution	-0.45%	-0.45%	-0.02%	-0.25%	-0.59%	-1.75%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.